Nyumbani » Wote » Utabiri wa Hisa » Viridian Therapeutics Inc. Common Stock Utabiri

Viridian Therapeutics Inc. Common Stock Utabiri: Kesho, Wiki, Mwezi, Miaka 5

Imesasishwa: April 22 · 2026 at 07:03 UTC
▼ -2.73%Market Cap $1.47B · Technical analysis Bearish · Focus area Price + volatility

Muhtasari wa Utabiri

Muda uliopangwaBei IliyotabiriwaZamaniKihistoriaMaarifa
Kesho$14.44 +1.15%Jana$14.21 -0.48%Tomorrow's Viridian Therapeutics Inc. Common Stock (VRDN) setup is anchored to $14.28 and targets $14.44 (+1.15%). The near-term read is upside; watch $14.71 / $13.85 because daily realized volatility is about 5.93%.
Tomorrow's Viridian Therapeutics Inc. Common Stock (VRDN) setup is anchored to $14.28 and targets $14.44 (+1.15%). The near-term read is upside; watch $14.71 / $13.85 because daily realized volatility is about 5.93%.
Wiki$14.79 +3.58%Wiki Iliyopita$14.07 -1.50%The 7-day Viridian Therapeutics Inc. Common Stock model moves from $14.07 to $14.79 (+3.58%). It gives upside momentum context for this stock, so breaks around $14.71 / $13.85 matter more than a single tick.
The 7-day Viridian Therapeutics Inc. Common Stock model moves from $14.07 to $14.79 (+3.58%). It gives upside momentum context for this stock, so breaks around $14.71 / $13.85 matter more than a single tick.
Mwezi$15.37 +7.61%Mwezi uliopita$13.82 -3.20%The 1-month Viridian Therapeutics Inc. Common Stock target is $15.37 (+7.61%), compared with the live reference near $14.28. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Viridian Therapeutics Inc. Common Stock target is $15.37 (+7.61%), compared with the live reference near $14.28. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Mwaka$16.23 +13.67%Mwaka jana$13.46 -5.74%The 1-year Viridian Therapeutics Inc. Common Stock scenario points to $16.23 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Viridian Therapeutics Inc. Common Stock scenario points to $16.23 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
Miaka 5$18.26 +27.86%Miaka 5 Iliyopita$12.61 -11.70%The 5-year Viridian Therapeutics Inc. Common Stock view is $18.26 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Viridian Therapeutics Inc. Common Stock view is $18.26 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Kesho$14.44 +1.15%
Jana$14.21 -0.48%
Tomorrow's Viridian Therapeutics Inc. Common Stock (VRDN) setup is anchored to $14.28 and targets $14.44 (+1.15%). The near-term read is upside; watch $14.71 / $13.85 because daily realized volatility is about 5.93%.
Wiki$14.79 +3.58%
Wiki Iliyopita$14.07 -1.50%
The 7-day Viridian Therapeutics Inc. Common Stock model moves from $14.07 to $14.79 (+3.58%). It gives upside momentum context for this stock, so breaks around $14.71 / $13.85 matter more than a single tick.
Mwezi$15.37 +7.61%
Mwezi uliopita$13.82 -3.20%
The 1-month Viridian Therapeutics Inc. Common Stock target is $15.37 (+7.61%), compared with the live reference near $14.28. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Mwaka$16.23 +13.67%
Mwaka jana$13.46 -5.74%
The 1-year Viridian Therapeutics Inc. Common Stock scenario points to $16.23 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
Miaka 5$18.26 +27.86%
Miaka 5 Iliyopita$12.61 -11.70%
The 5-year Viridian Therapeutics Inc. Common Stock view is $18.26 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Chati ya Bei

KihistoriaUtabiriBullishBearish
$15.09$14.77$14.45$14.13$13.811W AgoNow7D F

Uchambuzi wa Kiufundi

UzaSi upande wowoteNunua
Neutral
1
Bullish
3
Si upande wowote
1
Bearish

Viashiria Muhimu

KiashiriaThamaniMawimbi
Price$14.28 Mid
Daily Change-2.73% Below
Volatility Cap20.0% Mid
Confidence63% Above
Data Sourcenasdaq-screener Mid

Data ya Kihistoria

Current$14.28
Daily Change-2.73%
Market Cap$1.47B
Sourcenasdaq-screener
Current$14.28Daily Change-2.73%
Market Cap$1.47BSourcenasdaq-screener

Usaidizi & Viwango vya Upinzani

$13.85Support 1
$14.28Ya sasa
$14.71Resistance 1
shield
Support and resistance are estimated from the trusted current price until deeper historical data is available.

Bei Milestones

Viwango muhimu na muktadha wa kihistoria
Current$14.28Live reference price
Used as the anchor for generated forecast calculations.
Next Month$15.37Model projection+7.61%
Directional scenario based on capped drift.

Usahihi wa Utabiri

Jinsi mtindo wetu umefanya
63%
Mwelekeo
Generated market-data forecast
This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.
📊
Kanuni zetu husawazishwa upya kila wiki kwa kutumia hatua ya hivi punde ya bei, hali tete na viashiria vya viashirio. Usahihi hutofautiana kulingana na muda - kasi ya muda mfupi inaaminika zaidi kuliko makadirio ya muda mrefu.
Short term
63%
Direction confidence
Long term
Lower
Forecast uncertainty rises with horizon

Matukio ya Uwekezaji

Ikiwa utawekeza $1,000 katika VRDN leo
Bullish Scenario
$14.99
+5.00% from current
Bei Lengwa$14.99
MazingiraUpside momentum
Uwezekano55%
Base Scenario
$15.37
+7.61%
Bei Lengwa$15.37
MazingiraCapped drift
Uwezekano63%
Bearish Scenario
$13.57
-5.00% from current
Bei Lengwa$13.57
MazingiraVolatility drawdown
Uwezekano37%
Msingi: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Mambo ya Utabiri

Market Structure
Price structure reflects the latest momentum regime and support/resistance interaction.
Momentum Bullish · 66/100
24H drift+1.15%
7D drift+3.58%
30D drift+7.61%
Technical Signals
Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.
Mixed — Watching · 50/100
RSIn/a
MACDn/a
MA stackn/a
Macro Context
Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.
Risk-On Tentative · 64/100
1M outlook+7.61%
1Y outlook+13.67%
5Y outlook+27.86%

Maswali Yanayoulizwa Mara Kwa Mara

Q What is the Viridian Therapeutics Inc. Common Stock (VRDN) forecast for tomorrow?
Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Viridian Therapeutics Inc. Common Stock is projected near $14.44 versus the current reference around $14.28. That implies a modeled move of +1.15% over the next day, with realized prices still sensitive to intraday volatility.
Q What does the 7-day stock outlook suggest for VRDN?
The weekly Viridian Therapeutics Inc. Common Stock model points to $14.79, which maps to an expected drift of +3.58% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.
Q How should I read the Viridian Therapeutics Inc. Common Stock 1-month and 1-year targets?
The Viridian Therapeutics Inc. Common Stock 1-month target is $15.37 (+7.61%), while the 1-year target is $16.23 (+13.67%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.
Q Why does the Viridian Therapeutics Inc. Common Stock 5-year scenario differ from short-term rows?
The Viridian Therapeutics Inc. Common Stock long-horizon scenario sits near $18.26 with a modeled change of +27.86%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.
Q Where are VRDN support and resistance zones right now?
For Viridian Therapeutics Inc. Common Stock, nearest resistance is around $13.85, while nearest support is around $14.71. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.
Q How fresh is the Viridian Therapeutics Inc. Common Stock market snapshot?
The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.